(IN BRIEF) Thales and Avinor have partnered to implement a next-generation Unmanned Traffic Management (UTM) system across Norway, enabling the safe integration of unmanned and manned aircraft while adhering to European regulatory standards. Powered by Thales’ TopSky – UAS and … Read the full press release
Posted in Aviation & Aerospace, Business, Environment, Financial, France, Government, Industrial, Investment, Management, News, Norway, Security & Safety, Technology, Transportation & Logistics
Tagged Avinor, Christian Rivierre, INNOVATION, Mats Bye Gjertsen, Norway, partnership, safety, sustainability, Thales, Unmanned Traffic Management System
(IN BRIEF) Novartis has announced promising 96-week results from the Phase III ASC4FIRST trial, showcasing Scemblix® (asciminib) as a superior treatment for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP). Scemblix achieved significantly higher major … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged 96-week results, asciminib, ASH Annual Meeting, chronic myeloid leukemia, CML care, discontinuation rate, imatinib, major molecular response, MMR, National Comprehensive Cancer Network, NCCN, newly diagnosed settings, Novartis, oncology, Ph+ CML-CP, Phase II ASC2ESCALATE trial, Phase III ASC4FIRST trial, Philadelphia chromosome-positive chronic myeloid leukemia, safety, Scemblix, Second-Line Treatment, severe adverse events, standard-of-care, TKIs, tolerability, tyrosine kinase inhibitors
(IN BRIEF) AstraZeneca’s Imfinzi (durvalumab) has been granted Priority Review by the FDA for the treatment of muscle-invasive bladder cancer (MIBC), potentially becoming the first perioperative immunotherapy in this curative-intent setting. Supported by results from the NIAGARA Phase III trial, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AstraZeneca, bladder cancer, FDA, Imfinzi, Perioperative Immunotherapy, safety, Susan Galbraith
(IN BRIEF) Sampo plc has donated €50,000 to the Finnish Red Cross Disaster Relief Fund to support global humanitarian aid for those affected by natural disasters and conflicts. The fund provides essentials like food, water, shelter, and field hospitals, while … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Finland, Government, Industrial, Insurance, Investment, Management, News
Tagged donation, Finnish Red Cross Disaster Relief Fund, health, Johanna Tynkkynen, partnership, Red Cross, safety, Sampo, Sirpa Solehmainen, sustainability, well-being
(IN BRIEF) The European Commission has approved Theralugand®, Eckert & Ziegler’s high-purity Lutetium-177 chloride, for routine clinical use across the European Economic Area. This approval allows its application in targeted cancer therapies, such as for neuroendocrine tumors and metastatic prostate … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Cancer Therapies, Dr. Harald Hasselmann, Eckert & Ziegler, EU, Healthcare, safety, Theralugand®, wellness
(IN BRIEF) Boehringer Ingelheim has launched VETMEDIN® Solution, the first FDA-approved liquid treatment for congestive heart failure (CHF) in dogs caused by myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). The solution provides a convenient, twice-daily alternative to tablets, … Read the full press release
(IN BRIEF) Novartis has secured European Commission approval for Kisqali® (ribociclib) in combination with endocrine therapy (ET) as an adjuvant treatment for high-risk hormone receptor-positive (HR+), HER2-negative early breast cancer (EBC). The approval, based on the Phase III NATALEE trial, … Read the full press release
(IN BRIEF) Roche provided an update on its Phase III SKYSCRAPER-01 study, evaluating tiragolumab in combination with Tecentriq® for patients with PD-L1-high, advanced, or metastatic non-small cell lung cancer (NSCLC). The study did not meet its primary endpoint of improving … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Lung Cancer Therapy, Roche, safety, SKYSCRAPER-01 Study, TECENTRIQ, Tiragolumab
(IN BRIEF) Continental has introduced ATE SecuBrake, the first sustainably produced DOT 4 brake fluid free from hazardous materials requiring special labelling. Part of the ATE New Original line, it is designed for advanced braking systems, including those in electric … Read the full press release
(IN BRIEF) Experian is warning consumers and businesses to protect personal information during the Christmas season, as identity fraud spikes amid increased spending. New data shows fraud rates in the last quarter of the year have risen by 21% over … Read the full press release
Posted in Business, Economy, Financial, Government, Industrial, Internet & Online, Investment, Management, News, Security & Safety, Technology, United Kingdom
Tagged Christmas season, Experian, holidays, identity fraud, Paul Weathersby, safety, tips
(IN BRIEF) VINCI Highways has launched its winter operations program to ensure safe and accessible roads during challenging weather conditions. With a fleet of snowploughs, salt spreaders, and brine sprayers ready, along with strategic salt reserves, trained teams are on … Read the full press release
Posted in Berlin, Business, Financial, France, Industrial, Infrastructure & Utilities, Investment, Management, News, Security & Safety, Technology
Tagged Accessible Roads, holiday season, safety, VINCI Highways, Winter Operations
(IN BRIEF) AstraZeneca’s Tagrisso (osimertinib) has been recommended for approval in the EU for treating adult patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) with EGFR mutations who have not experienced disease progression after platinum-based chemoradiation therapy. This … Read the full press release
Posted in Business, European Union, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Dr. Manuel Cobo, safety, Susan Galbraith, Tagrisso, therapy, Unresectable EGFR-Mutated Lung Cancer
(IN BRIEF) SGS, in partnership with SkyeBase, has launched the Elios 3 UT Probe, a cutting-edge drone-mounted tool for ultrasonic thickness (UT) measurements. This technology allows safe, precise inspections in elevated or difficult-to-reach locations without the need for scaffolding or … Read the full press release
Posted in Belgium, Business, Electronics & Machinery, Environment, Financial, Government, Industrial, Investment, Management, News, Security & Safety, Switzerland, Technology
Tagged Belgium, Drone-Based Ultrasonic Tool, efficiency, Elios 3 UT Probe, Industrial Inspections, partnership, safety, SGS, SkyeBase
(IN BRIEF) Continental’s tires have excelled in European tire tests, winning 15 first-place rankings across various publications and automobile clubs. Their WinterContact series, including the TS 870 for small and midsize cars and the TS 870 P for more powerful … Read the full press release
Posted in Awards, Business, Environment, Financial, Germany, Industrial, Investment, Management, News, Security & Safety, Technology
Tagged All-Season Categories, Awards, Continental, European Tire Tests, leadership, performance, safety, sustainability, WINTER
(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP), reducing both nasal polyp size and congestion compared to a placebo. The WAYPOINT trial … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, Amgen, AstraZeneca, chronic rhinosinusitis, Dr. Brian Lipworth, Dr. Joseph Han, Healthcare, Nasal Polyp Symptoms, partnership, safety, Sharon Barr, sustainability, tezepelumab, Tezspire, USA
(IN BRIEF) TÜV Rheinland Hong Kong (TRHK) has been appointed as an official Third-Party Certification Body for “Type H” EV maintenance workshops under a new EMSD initiative in Hong Kong. This addition to the Voluntary Registration Scheme for Vehicle Maintenance … Read the full press release
(IN BRIEF) The European Medicines Agency has approved Dupixent as the first treatment for eosinophilic esophagitis (EoE) in young children aged one to 11, marking a significant step in managing this condition in a critical developmental phase. The approval is … Read the full press release
Posted in Business, Education, European Union, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Dr. George Yancopoulos, Dr. Houman Ashrafian, Dupixent, eosinophilic esophagitis, EU, European Medicines Agency (EMA), Healthcare, Regeneron, safety, Sanofi, treatment, wellness, Young Children
(IN BRIEF) SGS has introduced advanced laser diffraction technology at its Wavre, Belgium lab, enhancing its ability to measure droplet sizes in spray drug delivery systems. This investment in Malvern Spraytec technology allows for real-time data collection during the spray … Read the full press release
Posted in Belgium, Business, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Belgium, investment, Laser Diffraction Technology, Malvern Spraytec laser diffraction system, partnership, Pharmaceutical Spray Testing, safety, SGS, sustainability
(IN BRIEF) QIAGEN’s QIAstat-Dx Meningitis/Encephalitis Panel has received FDA clearance, enabling faster and more accurate diagnosis of critical CNS infections like meningitis and encephalitis. This panel, the fourth QIAstat-Dx test approved in the U.S. in 2024, uses real-time PCR to … Read the full press release
(IN BRIEF) Schmalz has launched the mGrip finger gripper, a hygienically designed pneumatic gripper tailored for sensitive food handling. Ideal for products like produce and baked goods, the mGrip’s gentle grip and closed, easy-to-clean design meet stringent hygiene standards, allowing … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?